Nuvation Bio Announces Departure of Chief Financial Officer
November 13 2023 - 4:05PM
Business Wire
Nuvation Bio Inc. (NYSE: NUVB) (the “Company”) announced today
that Jennifer Fox will be stepping down from her role as Chief
Financial Officer to pursue a new opportunity. Ms. Fox has advised
the Company that she is seeking later stage development and
commercial launch experience as part of her career development and
that she is leaving with a high regard for the Company, its
leadership and its financial state. Ms. Fox submitted her
resignation on November 9, 2023 with an effective date of November
27, 2023. Members of the executive management team and the
Company’s finance team will assume the duties and responsibilities
of the CFO office.
“Jen has played an integral role in helping to set the strategic
and financial direction for Nuvation Bio, and I want to thank her
for her dedication and hard work in moving Nuvation Bio forward,”
said David Hung, M.D., Founder, President, and Chief Executive
Officer of Nuvation Bio. “We owe her a great deal of gratitude for
her contributions and wish her all the best in her future
endeavors.”
About Nuvation Bio
Nuvation Bio is a biopharmaceutical company tackling some of the
greatest unmet needs in oncology by developing differentiated and
novel therapeutic candidates. Nuvation Bio’s proprietary portfolio
includes mechanistically distinct oncology therapeutic product
candidates, each targeting some of the most difficult-to-treat
types of cancer. Nuvation Bio was founded in 2018 by biopharma
industry veteran David Hung, M.D., who previously founded
Medivation, Inc., which brought to patients one of the world’s
leading prostate cancer medicines. Nuvation Bio has offices in New
York and San Francisco. For more information, please visit
www.nuvationbio.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231113617671/en/
Nuvation Bio Investor Contact: ir@nuvationbio.com
Nuvation Bio Media Contact:
nuvation@argotpartners.com
Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
From Apr 2024 to May 2024
Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
From May 2023 to May 2024